Login / Signup

Harnessing SARS-CoV-2-specific CD8 + T cells to kill target tumor cells for cancer immunotherapy.

Keunok JungDeok-Han KoJeong-Yun JangYoung Rong KimJung Yeon HeoYong-Sung Kim
Published in: Cancer communications (London, England) (2023)
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • big data
  • coronavirus disease